Stay updated on Zimura vs Sham in STGD1: Clinical Trial
Sign up to get notified when there's something new on the Zimura vs Sham in STGD1: Clinical Trial page.

Latest updates to the Zimura vs Sham in STGD1: Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, signaling a maintenance update to the entry. It does not change the study content, criteria, or results; it is a version bump.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s displayed build/version marker has been incremented from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor site release rather than a study-data update.SummaryDifference0.0%

- Check30 days agoChange DetectedAdded links to the results and plain-language summary on external sites. Updated revision from v3.5.0 to v3.5.2.SummaryDifference0.4%

- Check45 days agoChange DetectedAdded a Genetic and Rare Diseases Information Center resources entry, including Severe early-childhood-onset retinal dystrophy.SummaryDifference0.1%

- Check59 days agoChange DetectedResults were posted on 2026-03-12 for the study, detailing outcomes such as mean rate of change in the ellipsoid zone defect and changes in BCVA and macular sensitivity through Month 18. The results section also reports adverse events and other safety-related measurements collected up to 18 months.SummaryDifference3%

- Check66 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

Stay in the know with updates to Zimura vs Sham in STGD1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimura vs Sham in STGD1: Clinical Trial page.